LEADER 03929nam 2200613Ia 450 001 9910130880403321 005 20200520144314.0 010 $a1-283-40730-2 010 $a9786613407306 010 $a1-4443-4026-3 010 $a1-4443-4028-X 035 $a(CKB)3460000000000068 035 $a(EBL)661848 035 $a(OCoLC)711780395 035 $a(SSID)ssj0000506273 035 $a(PQKBManifestationID)11341143 035 $a(PQKBTitleCode)TC0000506273 035 $a(PQKBWorkID)10512904 035 $a(PQKB)11502504 035 $a(MiAaPQ)EBC661848 035 $a(EXLCZ)993460000000000068 100 $a20101210d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aClinical dilemmas in diabetes /$fedited by Adrian Vella, Robert A. Rizza 210 $aChichester, West Sussex, UK ;$aHoboken, NJ $cWiley-Blackwell Publishing$d2011 215 $a1 online resource (171 p.) 225 1 $aClinical Dilemmas (UK) 300 $aDescription based upon print version of record. 311 $a1-4051-6928-1 320 $aIncludes bibliographical references and index. 327 $aClinical Dilemmas inDiabetes; Contents; Contributors; Preface; Part I Prediabetes and the Diagnosis of Diabetes; 1 Is prediabetes a risk factor or is it a disease?; 2 Early diagnosis of type 1 diabetes: Useful or a phyrrhic victory?; 3 How should secondary causes of diabetes be excluded?; 4 Screening patients with prediabetes and diabetes for cardiovascular disease; Part II Initial Evaluation and Management of Diabetes 327 $a5 What is the role of self-monitoring in diabetes? Is there a role for postprandial glucose monitoring? How does continuous glucose monitoring integrate into clinical practice?6 The optimal diet for diabetes is?; 7 How to determine when to pursue lifestyle change alone versus pharmacotherapy at diagnosis?; 8 Insulin sensitizers versus secretagogues as first-line therapy for diabetes: Rationale for clinical choice; 9 Are insulin sensitizers useful additions to insulin therapy?; 10 Is there a role for incretin-based therapy in combination with insulin? 327 $a11 HbA1c: Is it the most important therapeutic target in outpatient management of diabetes?Part III Management of Associated Risk Factors and Disease; 12 Primary therapy for obesity as the treatment of type 2 diabetes; 13 Are statins the optimal therapy for cardiovascular risk in patients with diabetes? Are triglycerides an important independent risk factor for diabetes?; 14 The role of bariatric surgery in obese patients with diabetes: Primary or rescue therapy?; 15 Hyperglycemia should be avoided in critical illness and the postoperative period 327 $a16 Is there an optimal revascularization strategy in diabetic patients with ischemic heart disease?Index 330 $aClinical Dilemmas in Diabetes provides evidence-based clinical guidance on the most common and problematic areas of concern encountered in diagnosing, treating and managing patients with diabetes. Each chapter is highly topical and has been selected due to current interest, specific recent developments, and areas of controversy. This valuable guide provides assistance in managing the life-long treatment of diabetes and the complications that often develop in patients. Clinical Dilemmas in Diabetes guides the medical team in their decision-making, particularly when there are con 410 0$aClinical Dilemmas (UK) 606 $aDiabetes 606 $aEvidence-based medicine 615 0$aDiabetes. 615 0$aEvidence-based medicine. 676 $a616.4/62 701 $aRizza$b Robert$01763391 701 $aVella$b Adrian$0860606 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910130880403321 996 $aClinical dilemmas in diabetes$94203782 997 $aUNINA